Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection

Blood

Volumn 96, Issue 9, 2000, Pages 3094-3101

  Shankar, P ^a   Russo, M ^a   Harnisch, B ^a   Patterson, M ^a   Skolnik, P ^a   Lieberman, J ^a  

^a CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ARTICLE; CELL DEATH; CHRONIC DISEASE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOBLASTOID CELL; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

EID: 0034330698     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.9.3094     Document Type: Article

References (61)

1. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
2. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
3. The immunology of primary HIV infection: Which immune responses control HIV replication?
4. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS
5. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
6. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
7. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
8. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques
9. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
10. Cytotoxic T-lymphocyte escape viral variants: How important are they in viral evasion of immune clearance in vivo?
11. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
12. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation
13. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
14. How does the HIV escape cytotoxic T cell immunity?
15. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein
16. Virus escape from CTL recognition
17. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
18. Viral immune evasion due to persistence of activated T cells without effector function
19. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells
20. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and down-modulate CD3ζ, the signaling chain of the T-cell receptor complex
21. HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression
22. Decreased expression of ζ molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons
23. Phenotypic analysis of antigen-specific T lymphocytes
24. Rapid effector function in CD8+ memory T cells
25. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia
26. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
27. Rapid determination of Epstein-Barr virus-specific CD8+ T cell frequencies by flow cytometry
28. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers
29. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides
30. Effective lysis of HIV-1-infected primary CD4+ T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope
31. Viral-specific cytotoxic T lymphocytes lyse HIV-infected primary T lymphocytes by the granule exocytosis pathway
32. Effects of human immunodeficiency virus on the cellular immune response to Epstein-Barr virus in homosexual men: Characterization of the cytotoxic response and lymphokine production
33. Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects
34. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase
35. Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers
36. Distinct kinetics of cytokine production and cytolysis in effector and memory cells after viral infection
37. HIV-specific circulating CD8 T lymphocytes have down-modulated CD3ζ and CD28, key signaling molecules for T cell activation
38. Cytotoxic T lymphocyte epitopes: Implications for HIV vaccines
39. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: Evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms
40. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
41. CD4+ T cell memory, CD45R subsets and the persistence of antigen - A unifying concept
42. Phenotypic and functional separation of memory and effector human CD8+ T cells
43. Increased expression of Bcl2 in antigen-specific memory CD8+ T cells
44. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: Results of 6 years of follow-up
45. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression
46. HIV - The immune response
47. T cell epitope mapping by flow cytometry
48. Multispecific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: Factors other than the MHC control the epitopic specificities
49. Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes
50. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
51. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
52. Human immunodeficiency virus type 1 and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD+ T cells
53. Immunological memory
54. Massive expansion of antigen-specific CD8+ T cells during an acute virus
55. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)
56. Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts
57. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
58. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection
59. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
60. Help for cytotoxic T cell responses is mediated by CD40 signalling
61. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions